Trial NCT05581719

View at ClinicalTrials.gov 
Org. Study IDs: ENX-CL-04-002a

Last trial update was posted on 2024-04-17

MeSH Interventions

Nivolumab Tislelizumab

MeSH Conditions

Neoplasm Metastasis Neoplasms

Other Conditions

Peritoneal Cancer Peritoneal Metastases Solid Tumor

Stopping Reasons

Sponsor decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID